The company, which is a world leader in biotechnology, is creating a new polyclonal antibody production
site.This is an innovative production facility: the process has been automated as far as possible, to reduce
human error in the many stages of the process (separation, purification, filtration, ultrafiltration,
haemadsorption etc.).This involves being able to interface with a battery of very mixed laboratory equipment,
which was not initially designed to communicate with fieldbuses. Genzyme has used about thirty HMS
Anybus Communicator gateways, to enable consistent SCADA management across all the devices in use.
Benefits are as much in terms of quality as in production costs